RDY logo

RDY
Dr. Reddy's Laboratories Ltd.

618
Mkt Cap
$11.42B
Volume
2.15M
52W High
$16.17
52W Low
$12.77
PE Ratio
17.60
RDY Fundamentals
Price
$13.72
Prev Close
$13.64
Open
$13.67
50D MA
$13.80
Beta
0.40
Avg. Volume
2.63M
EPS (Annual)
$0.8029
P/B
2.76
Rev/Employee
$138,447.28
$10,916.67
Loading...
Loading...
News
all
press releases
AMPH vs. RDY: Which Stock Should Value Investors Buy Now?
AMPH vs. RDY: Which Stock Is the Better Value Option?
Zacks·3d ago
News Placeholder
More News
News Placeholder
Dr. Reddy's Laboratories Announces Health Canada Approval for Generic Semaglutide Injection in Canada
Dr. Reddys Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY; along with its subsidiaries together referred to as Dr. Reddys), a global pharmaceutical company, today announced...
Business Wire·3d ago
News Placeholder
AMRX Valuation: What 1.69x Sales Means for Investors
Amneal trades at 1.69x sales, below sector benchmarks, as investors weigh raised 2026 profit guidance against Specialty pressure and launch execution.
Zacks·4d ago
News Placeholder
Dr. Reddy's Laboratories Ltd $RDY Shares Acquired by B. Metzler seel. Sohn & Co. AG
B. Metzler seel. Sohn & Co. AG increased its holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 912.6% during the fourth quarter, according to its most recent filing with the...
MarketBeat·9d ago
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Rating Lowered to Sell at The Goldman Sachs Group
The Goldman Sachs Group downgraded shares of Dr. Reddy's Laboratories from a "neutral" rating to a "sell" rating in a report on Thursday...
MarketBeat·9d ago
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What Happened
Dr. Reddy's Laboratories (NYSE:RDY) Shares Gap Up - Here's What Happened...
MarketBeat·9d ago
News Placeholder
Dr. Reddy's Laboratories (NYSE:RDY) Sets New 1-Year Low - Time to Sell?
Dr. Reddy's Laboratories (NYSE:RDY) Sets New 52-Week Low - Time to Sell...
MarketBeat·11d ago
News Placeholder
JPMorgan Chase & Co. Buys 116,924 Shares of Dr. Reddy's Laboratories Ltd $RDY
JPMorgan Chase & Co. boosted its stake in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 2.0% in the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 6,027,710 shares of the company's sto...
MarketBeat·1mo ago
News Placeholder
ESPR's Q4 Earnings Lag Estimates, Revenues Beat, Stock Down
Esperion Therapeutics' Q4 revenues surge 144% to $168.4M but EPS of 22 cents misses estimates. Shares fall as mixed results weigh on sentiment.
Zacks·2mo ago
News Placeholder
American Century Companies Inc. Acquires 144,530 Shares of Dr. Reddy's Laboratories Ltd $RDY
American Century Companies Inc. grew its holdings in Dr. Reddy's Laboratories Ltd (NYSE:RDY - Free Report) by 13.8% in the 3rd quarter, according to the company in its most recent 13F filing with the...
MarketBeat·2mo ago
<
1
2
...
>

Latest RDY News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.